Carbamazepine induced Stevens Johnson Syndrome: a case report from a tertiary care hospital

Jyoti B. Gadhade, Rajesh S. Hiray, Balasaheb B. Ghongane


Stevens Johnson Syndrome is a rare but life-threatening skin disease and Carbamazepine is considered as one of the most common cause. The reported frequency of serious Carbamazepine hypersensitivity reaction is between 1/1000 and 1/10000 new exposures to the drug. Here, we report a case of a 40 year old female patient, who developed multiple ulcerative lesions all over the body three days after starting treatment with Carbamazepine for Trigeminal Neuralgia. (Worldwide Unique Number- 2017-58502 and AMC Report Number- BJGMC-Pune/Nov-2017/BBG-1860) Stevens Johnson Syndrome was diagnosed. Carbamazepine was withdrawn, and the patient was treated with topical and intravenous antibiotics. A biopsy was done which confirmed the diagnosis of Stevens Johnson Syndrome.


Adverse drug reaction, Carbamazepine, Stevens Johnson Syndrome

Full Text:



Acquier DA, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC, et al. Correlations between clinical patterns and causes of erythema multiforme, Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019-24.

Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, foster CS. Stevens Johnson Syndrome and Toxic epidermal Necrolysis: A review of the literature. Ann Allergy asthma Immunol. 2005;94:419-36.

Devi K, George S, Criton S, Suja V, Sridevi PK. Carbamazepine- The commonest cause of Toxic Epidermal Necrolysis and Stevens Johnson Syndrome: A study of 7 years Indian J Dermatol Venereol Leprol. 2005;71:325-8.

Sharma VK, Sethuraman G, Minz A. Stevens Johnson Syndrome, Toxic Epidermal Necrolysis and SJS-TEN overlap: A retrospective study of causative drugs and clinical outcome. Indian J Dermatol Venereol Leprol. 2008;74:238-40.

Sharma VK, Sethuraman G. Adverse cutaneous reactions to drugs: An overview. J Postgraduate Med. 1996;42:15-22.

Paul C, Wolkensten P, Adle H, Wechsler J, Garchon HJ, Revuz J, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol. 1996;134:710-4.

Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Cli Epidemiol. 1996 Jul 1;49(7):769-73.

Leeder JS. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs- Epilepsia. 1998;39(7):S8-16.

Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997;49:542-6.

Larsen A, Piepgras D, Chyatte D, Rizzolo D. Trigeminal Neuralgia. diagnosis and medical and surgical management. JAAPA. 2011;24:20-5.

Harr T, French LE. Toxic Epidermal necrolysis and Stevens Johnson Syndrome. Orph J Rare Diseas. 2010;5(1):39.

Bastuji-Garin S, Fouchard N, Bertocchi M, Rocyeau JC, Revuz J, Wolkenstein P. SCORTEN of Investigative Dermatology. 2000;115(2):149-53.

Yun SJ, Choi MS, Piao MS, Lee JB, Kim SJ, Won VH, et al. Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of Toxic Epidermal Necrolysis. Dermatology 2008;217:254-9.

Devi K. The association of HLA B*15:02 Allele and Stevens Johnson Syndrome/toxic epidermal necrolysis induced by aromatic anti convulsant drugs in a South Indian Population. Int J Dermatol. 2018;57(1):70-3.

Ou GJ, Wang J, Ji X, Yu H, Jiang L, Li L, et al. A study of HLA‐B* 15: 02 in 9 different Chinese ethnics: Implications for carbamazepine related SJS/TEN. Hla. 2017 Apr;89(4):225-9.

Guleria. Oxcarbazepine induced toxic epidermal necrolysis. Ind J of Pharmacol. August 2015;47(4):459-61.

Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, et al. Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 2006;118:233-41.

Bae HM, Park YJ, Kim YH, Moon DE. Stevens-johnson syndrome induced by carbamazepine treatment in a patient who previously had carbamazepine induced pruritus-a case report. The Kore J Pain. 2013 Jan 1;26(1):80-3.